EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSCMIG00000006524
Gene Symbol: PSMD6
4 Cross references
214 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSCMIG00000013835
Gene Symbol: PSMD7
1 Cross references
248 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSCMIG00000005178
Gene Symbol: PSMD8
3 Cross references
213 Possible Orthologues:

Proteasome Subunit Alpha Type-4

Ensembl ID : ENSCMIG00000001428
Gene Symbol: LOC103171909
3 Cross references
254 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSCMIG00000001243
Gene Symbol: PSMB11
1 Cross references
223 Possible Orthologues:

Proteasome Subunit Beta Type-7-Like

Ensembl ID : ENSCMIG00000006398
Gene Symbol: LOC103171675
2 Cross references
217 Possible Orthologues:

Proteasome Subunit Beta Type-8-Like

Ensembl ID : ENSCMIG00000006394
Gene Symbol: LOC103171674
3 Cross references
226 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSCMIG00000010158
Gene Symbol: LOC103175221
4 Cross references
211 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSCMIG00000012131
Gene Symbol: PRKCB
3 Cross references
304 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSCMIG00000020018
Gene Symbol: PRKCD
4 Cross references
283 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSCMIG00000005496
Gene Symbol: PRKCE
3 Cross references
348 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSCMIG00000003742
Gene Symbol: PRKCH
3 Cross references
241 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).